306 related articles for article (PubMed ID: 15934071)
1. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
Francès C; Niang S; Laffitte E; Pelletier Fl; Costedoat N; Piette JC
Arthritis Rheum; 2005 Jun; 52(6):1785-93. PubMed ID: 15934071
[TBL] [Abstract][Full Text] [Related]
2. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
Kriseman YL; Nash JW; Hsu S
J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
4. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
5. Features associated with epilepsy in the antiphospholipid syndrome.
Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J
J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954
[TBL] [Abstract][Full Text] [Related]
6. [Dermatologic manifestations of the antiphospholipid syndrome].
Francès C; Barete S; Soria A
Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802
[TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
9. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus.
Francès C; Piette JC
J Autoimmun; 2000 Sep; 15(2):139-43. PubMed ID: 10968900
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of antiphospholipid antibody syndrome.
Weinstein S; Piette W
Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Sapporo criteria for antiphospholipid syndrome.
Lockshin MD; Sammaritano LR; Schwartzman S
Arthritis Rheum; 2000 Feb; 43(2):440-3. PubMed ID: 10693886
[TBL] [Abstract][Full Text] [Related]
12. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus.
Font J; Ramos-Casals M; Brito-Zerón P; Nardi N; Ibañez A; Suarez B; Jiménez S; Tàssies D; García-Criado A; Ros E; Sentís J; Reverter JC; Lozano F
Rheumatology (Oxford); 2007 Jan; 46(1):76-80. PubMed ID: 16801331
[TBL] [Abstract][Full Text] [Related]
13. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 61 patients with antiphospholipid syndrome].
Leng XM; Liu XM; Ai MX; Zeng XF; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1367-70. PubMed ID: 15387947
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations associated with antiphospholipid antibodies.
Diógenes MJ; Diógenes PC; de Morais Carneiro RM; Neto CC; Duarte FB; Holanda RR
Int J Dermatol; 2004 Sep; 43(9):632-7. PubMed ID: 15357740
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
17. Ocular manifestations in antiphospholipid syndrome.
Suvajac G; Stojanovich L; Milenkovich S
Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
[TBL] [Abstract][Full Text] [Related]
18. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
Krause I; Lev S; Fraser A; Blank M; Lorber M; Stojanovich L; Rovensky J; Chapman J; Shoenfeld Y
Ann Rheum Dis; 2005 Oct; 64(10):1490-3. PubMed ID: 15778242
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
20. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
